1. Corporate Officers - D
2. Dachille Douglas A.

Insider Trading History of Dachille Douglas A.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Dachille Douglas A. since 2018. This trader's CIK number is 1652908. At the time of last reporting, Dachille Douglas A. was the Director of Bridgebio Pharma, Inc.. (stock ticker symbol BBIO). Also see all insider trading activities at Bridgebio Pharma, Inc..

Note that in the past Dachille Douglas A. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at American International Group, Inc. (AIG) by Dachille Douglas A.

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2021	AIG	0	$0	0	$0	29,200	$0
2020	AIG	0	$0	0	$0	25,953	$0
2019	AIG	0	$0	0	$0	120,288	$0
2018	AIG	0	$0	0	$0	5,680	$0

Yearly summary of insider trading at Bridgebio Pharma, Inc. (BBIO) by Dachille Douglas A.

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2022	BBIO	20,000	$245,580	0	$0	0	$0

Insider trading activities at 2 companies by Dachille Douglas A.:

1. American International Group, Inc. (AIG)

2. Bridgebio Pharma, Inc. (BBIO)

Table 1. Insider trading of American International Group, Inc. (AIG) by Dachille Douglas A.

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2021-01-01	AIG	Option Ex	29,200	.00	0
2020-01-01	AIG	Option Ex	25,953	.00	0
2019-03-29	AIG	Option Ex	826	.00	0
2019-03-15	AIG	Option Ex	113,633	.00	0
2019-01-01	AIG	Option Ex	5,829	.00	0
2018-01-17	AIG	Option Ex	5,680	.00	0

Table 2. Insider trading of Bridgebio Pharma, Inc. (BBIO) by Dachille Douglas A.

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2022-03-14	BBIO	Buy	10,000	8.19	81,930
2022-01-05	BBIO	Buy	5,000	15.91	79,550
2022-01-04	BBIO	Buy	5,000	16.82	84,100

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dachille Douglas A. (Director of Bridgebio Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month